Department of Microbiology and Immunology, University of British Columbia, Vancouver, BC, Canada; Michael Smith Laboratories, University of British Columbia, Vancouver, BC, Canada.
Swiss Institute of Allergy and Asthma Research, University of Zurich, Davos, Switzerland; Christine Kühne - Center for Allergy Research and Education (CK-CARE), Davos, Switzerland.
Immunity. 2020 Feb 18;52(2):241-255. doi: 10.1016/j.immuni.2020.01.007.
Asthma is a common chronic respiratory disease affecting more than 300 million people worldwide. Clinical features of asthma and its immunological and molecular etiology vary significantly among patients. An understanding of the complexities of asthma has evolved to the point where precision medicine approaches, including microbiome analysis, are being increasingly recognized as an important part of disease management. Lung and gut microbiota play several important roles in the development, regulation, and maintenance of healthy immune responses. Dysbiosis and subsequent dysregulation of microbiota-related immunological processes affect the onset of the disease, its clinical characteristics, and responses to treatment. Bacteria and viruses are the most extensively studied microorganisms relating to asthma pathogenesis, but other microbes, including fungi and even archaea, can potently influence airway inflammation. This review focuses on recently discovered connections between lung and gut microbiota, including bacteria, fungi, viruses, and archaea, and their influence on asthma.
哮喘是一种常见的慢性呼吸道疾病,影响着全球超过 3 亿人。哮喘的临床特征及其免疫学和分子病因在患者之间有很大差异。对哮喘复杂性的认识已经发展到这样一个地步,即包括微生物组分析在内的精准医疗方法越来越被认为是疾病管理的重要组成部分。肺和肠道微生物群在健康免疫反应的发展、调节和维持中发挥着几个重要作用。微生物群相关免疫过程的失调和随后的失调会影响疾病的发作、其临床特征和对治疗的反应。细菌和病毒是与哮喘发病机制关系最密切的微生物,但其他微生物,包括真菌甚至古菌,也能强烈影响气道炎症。本综述重点介绍了最近发现的肺和肠道微生物群(包括细菌、真菌、病毒和古菌)之间的联系,以及它们对哮喘的影响。